NDC 0781-7249-06 - BUPRENORPHINE AND NALOXONE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0781-7249
- Requested NDC
- 0781-7249-06
- Package NDCs from labels
- 0781-7249-06, 0781-7249-64
- Manufacturer
- Indivior Inc.
- Effective date
- 2021-04-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| BUPRENORPHINE AND NALOXONE - Indivior Inc. | Indivior Inc. | 2021-04-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0781-7249-06 | EA - Each | 0781-7249 | 1bb36689-3c63-4b20-b327-05bc578f5337 | 1 | 2019-10-07 |
| 0781-7249-64 | EA - Each | 0781-7249 | 064c1984-7eb1-4e07-8102-b7b4b7aeabae | 1 | 2019-03-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE | Redpharm Drug | 44f2e26f-4586-5204-e063-6394a90a47d5 | 2026-01-23 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine HCl | BUPRENORPHINE HCL | Camber Pharmaceuticals, Inc. | b52cea0e-688f-4beb-bf7d-f228b81dbd23 | 2026-01-23 | Warnings, Adverse reactions | 56W8MW3EN1 |
| SWISS BLEU Relief-Calm Antimicrobial Skin Cream | LACTOBACILLUS FERMENT LYSATE, LEONTOPODIUM ALPINUM, CALENDULA OFFICINALIS FLOWER EXTRACT, EVENING PRIMROSE FLOWER EXTRACT, CITRIC ACID | Nanjing Hongruixing Biological Technology Co., Ltd | 487d3c2c-ce28-f7a1-e063-6294a90a5ec6 | 2026-01-16 | Warnings | 2968PHW8QP |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Mylan Pharmaceuticals Inc. | 557d8d4d-8751-431c-b18e-9d5cf23fc579 | 2026-01-15 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | AvKARE | 1766a7f1-d301-945f-e063-6294a90ac6f4 | 2026-01-14 | Warnings | F850569PQR |
| RiVive | NALOXONE HYDROCHLORIDE | Harm Reduction Therapeutics, Inc. | 1c4f1b9d-1c70-4666-a90e-2f5d2c670d4d | 2026-01-13 | Warnings | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Sina Health Inc | 2879294f-9af9-459e-e063-6394a90a0820 | 2026-01-12 | Warnings, Adverse reactions | F850569PQR |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Dr.Reddys Laboratories Inc | 718756d7-0131-b173-6c45-5ee039b311b0 | 2026-01-12 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine and Naloxone | BUPRENORPHINE AND NALOXONE | Dr.Reddys Laboratories Inc | 72dc1ec0-7c59-a587-4ffd-c40ef79e6fb2 | 2026-01-12 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine | BUPRENORPHINE | AvPAK | 1408cd8f-a0b5-6be7-e063-6394a90a0b41 | 2026-01-08 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine HCl and Naloxone HCl | BUPRENORPHINE AND NALOXONE | AvPAK | b955054b-b37d-4079-4fed-5939b763ecb4 | 2026-01-08 | Warnings, Adverse reactions | 56W8MW3EN1 |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | Padagis Israel Pharmaceuticals Ltd | b5d40220-f194-4835-b70c-f304ecb222d5 | 2026-01-06 | Warnings | F850569PQR |
| BELBUCA | BUPRENORPHINE HYDROCHLORIDE | BioDelivery Sciences International Inc | bc2b7a3d-72cf-497c-95b0-ba2b71f63c64 | 2026-01-02 | Boxed warning, Warnings, Adverse reactions | 56W8MW3EN1 |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Dr. Reddy's Laboratories, Inc. | b1303f15-c48b-a44d-b28a-72f370094e02 | 2026-01-01 | Warnings, Adverse reactions | F850569PQR |
| Buprenorphine and Naloxone Sublingual Film | BUPRENORPHINE AND NALOXONE | Alvogen Inc. | 4210afeb-474c-d842-d68e-af7e0021851a | 2026-01-01 | Warnings, Adverse reactions | 56W8MW3EN1 |
| Buprenorphine Hydrochloride | BUPRENORPHINE HYDROCHLORIDE | Hospira, Inc. | 23aa1bb3-cecf-4e62-29bb-48488bb66fc3 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | 56W8MW3EN1 |
| Discount Drug Mart Eye Drops Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Discount Drug Mart | f7fd53be-e501-d97f-e053-6394a90ad409 | 2025-12-30 | Warnings | 3NXW29V3WO |
| Exchange Select Artificial Tears Lubricant Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Army and Air Force Exchange Service | 9e478343-8ae7-823e-e053-2995a90a84ed | 2025-12-30 | Warnings | 3NXW29V3WO |
| DG Health Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYPROPYLENE GLYCOL 400 | Dolgencorp LLC | 9cb20c3b-bf6d-8c7c-e053-2995a90aa485 | 2025-12-30 | Warnings | 3NXW29V3WO |
| Core Values Eye Drops Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Liberty Procurement Co. Inc. | f8285f68-c40c-19a8-e053-6394a90aacad | 2025-12-30 | Warnings | 3NXW29V3WO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.